Cargando…
Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas
We encountered a family of Japanese descent in which multiple members developed lung cancer. Using whole-exome sequencing, we identified a novel germline mutation in the transmembrane domain of the human epidermal growth factor receptor 2 (HER2) gene (G660D). A novel somatic mutation (V659E) was als...
Autores principales: | Yamamoto, Hiromasa, Higasa, Koichiro, Sakaguchi, Masakiyo, Shien, Kazuhiko, Soh, Junichi, Ichimura, Koichi, Furukawa, Masashi, Hashida, Shinsuke, Tsukuda, Kazunori, Takigawa, Nagio, Matsuo, Keitaro, Kiura, Katsuyuki, Miyoshi, Shinichiro, Matsuda, Fumihiko, Toyooka, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906987/ https://www.ncbi.nlm.nih.gov/pubmed/24317180 http://dx.doi.org/10.1093/jnci/djt338 |
Ejemplares similares
-
Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer
por: Shien, Kazuhiko, et al.
Publicado: (2014) -
Induction Chemoradiotherapy Followed by Surgical Resection for Clinical T3 or T4 Locally Advanced Non–Small Cell Lung Cancer
por: Shien, Kazuhiko, et al.
Publicado: (2012) -
Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER2 oncogene alterations
por: Suzawa, Ken, et al.
Publicado: (2015) -
TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells
por: Otani, Hiroki, et al.
Publicado: (2015) -
Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib
por: Hashida, Shinsuke, et al.
Publicado: (2015)